Φορτώνει......
Salivary lactoferrin as biomarker for Alzheimer's disease: Brain‐immunity interactions
OBJECTIVE: We aim to explain why salivary lactoferrin (Lf) levels are reduced in patients suffering mild cognitive impairment (MCI) and sporadic Alzheimer's disease (sAD).(1) We also will discuss if such Lf decrease could be due to a downregulation of the sAD associated systemic immunity. BACKG...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Alzheimers Dement |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7984071/ https://ncbi.nlm.nih.gov/pubmed/32543760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/alz.12107 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|